19 Analysts Have This to Say About Pfizer
Portfolio Pulse from Benzinga Insights
In the last quarter, 19 analysts have provided ratings for Pfizer (NYSE:PFE), with a majority being bullish or somewhat bullish. The company has an average 12-month price target of $49.74, with a high of $75.00 and a low of $33.00. This average price target has increased by 14.24% over the past month.
October 20, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer has received mostly bullish ratings from 19 analysts in the last quarter. The average 12-month price target is $49.74, which has increased by 14.24% over the past month.
The majority of the 19 analysts have given Pfizer a bullish or somewhat bullish rating, indicating a positive outlook for the company. The increase in the average 12-month price target over the past month also suggests growing confidence in the company's performance. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100